Cost sharing Requirements for Insulin and Diabetes Supplies (HB 367)
Score:
0
%
Florida
2026
Caps what patients pay for diabetes care. Insurers in Florida cannot charge more than $35 for a 30-day supply of insulin, and no more than $100 for 30 days of diabetes supplies like test strips, glucometers, continuous monitors, lancets, and syringes, no matter the brand or amount. Applies to most health plans issued, renewed, or changed on or after Jan 1, 2027. Takes effect July 1, 2026. Lowers out-of-pocket costs and improves access.
Vote Yes on this bill if you want to cap patient costs at no more than $35 for 30 days of insulin and $100 for 30 days of diabetes supplies across most health plans.
Organizations that support this bill may include diabetes advocacy groups, patient and senior organizations, public health groups, and community clinics seeking lower out-of-pocket costs.
Supported By
Vote No on this bill if you want insurers to keep setting their own cost-sharing amounts for insulin and diabetes supplies without state caps.
Organizations that oppose this bill may include health insurers, pharmacy benefit managers, and some employer and business associations concerned about higher premiums or plan costs.
